The slip
PARKINSON RECEIPTno. 6798
22 Oct 2026, 20:46 UTCdopamine neurons, braak
predictionCASP8 in dopamine neurons tracks Braak Lewy-body stage
registerede95fd0895153a879
discovery+0.11 p=0.777 n=9
replication-0.20 p=0.607 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.11, p 0.777)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT7ca4649fbc4f96e1434de96d…
follows a17ffa346845…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6798: CASP8 in dopamine neurons, braak
- power
- full sample +0.03 (p 0.915, n 18), 95% CI -0.45 to +0.49. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.02 (p 0.928, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.02 (p 0.942, n 18). could be the mix.
- skeptic
- leave-one-out range -0.04 to +0.16, sign flips 7; without severely affected donors +0.03 (p 0.915, n 18). fragile.
- cell type
- strongest in microglia: -0.65 (p 0.0034, n 18) vs +0.03 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CASP8 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up CASP8 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.30 p 0.286 (needs p < 3.1e-4)